Patient presents with [signs/symptoms such as developmental delay, intellectual disability, seizures, psychiatric disorders, thromboembolic events, or lens dislocation] suggestive of a homocystinuria or other related homocysteine disorder.  Family history is significant for [family history findings, if any, such as consanguinity or similar presentations in family members].  Physical examination revealed [relevant physical exam findings, such as Marfanoid habitus, ectopia lentis, or signs of thromboembolism].  Initial laboratory evaluation shows [elevated homocysteine levels in blood andor urine].  Differential diagnosis includes other causes of hyperhomocysteinemia such as vitamin B12 deficiency, folate deficiency, renal disease, and certain medications.  Metabolic testing, including plasma amino acid analysis and urine organic acid analysis, is being performed to confirm the diagnosis and identify the specific enzymatic defect  e.g., cystathionine beta-synthase deficiency, methylenetetrahydrofolate reductase deficiency.  Genetic testing may be considered to confirm the diagnosis and assess for specific mutations.  Treatment plan includes dietary modifications, such as a methionine-restricted diet, and supplementation with pyridoxine (vitamin B6), folate, andor vitamin B12, depending on the specific enzyme defect.  Patient education regarding the importance of adherence to treatment and regular monitoring of homocysteine levels was provided.  Referral to a metabolic specialist andor geneticist may be warranted for further evaluation and management of this complex disorder.  ICD-10 code E72.1  disorders of sulfur amino-acid metabolism  will be utilized for billing and coding purposes.  Continued monitoring for complications such as thrombosis, osteoporosis, and ocular issues is essential.